Our organization requires the NIH's Citi training prior to any research activity. Especially if human subjects may be involved.

Best,
Tammy L. Jobes, DBA
Phone: 651-229-3992 | Fax: 651-229-1767
Email: xxxxxx@gillettechildrens.com
Research Correspondence: xxxxxx@gillettechildrens.com
Normal Business Hours: 7:00 a.m. to 4 p.m. Central time

-----Original Message-----
From: xxxxxx@lists.healthresearch.org <xxxxxx@lists.healthresearch.org> On Behalf Of Erin Fogarty
Sent: Monday, January 6, 2025 12:14 PM
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] Quick question re: GCP and clinical trials

Stop, Look, and Think. Do you trust this email? If it looks suspicious, DO NOT CLICK on links or attachments. Please use the Phish Alert Button to report it.

I'm used to all clinical faculty having their GCP certification (Good Clinical Practice) regardless of the type of trial?
My VP is asking if fellow or students need to be GCP certified before participating in a clinical trial (a non-NIH clinical trial).
        I disagree and welcome anyone's experience on this topic.
And, does your institution have a carve out for studies, in cases such as chart reviews (meaning GCP not required -assuming it's not an NIH clinical trial).

Any input welcome.

Erin Fogarty, MA, CRA
Executive Director, MetroHealth Research Institute (affiliated with Case Western Reserve University)

MetroHealth’s Mission: Leading the way to a healthier you and a healthier community through service, teaching, discovery, and teamwork. This email and all attachments that may have been included are intended only for the use of the party to whom/which the email is addressed and may contain information that is privileged, confidential, or exempt from disclosure under applicable law. If you are not the addressee or the employee or agent of the intended recipient, you are hereby notified that you are strictly prohibited from printing, storing, disseminating, distributing, or copying this communication.Contact us<https://fs26.formsite.com/8dBVlg/sjvmjw2v0c/index.html>
- = - = - = - = - = - = -

This email was sent to xxxxxx@gillettechildrens.com via the Research Administrator's mailing list.

To unsubscribe from RESADM-L, go to https://lists.healthresearch.org and enter your subscribed email address into the "My account and unsubscriptions" area at the bottom of the page.  This also allows you to switch to Digest Mode or to temporarily suspend emails.  You will be emailed a link to change all these settings.

List archives are available at:  https://lists.healthresearch.org/resadm-l

Please keep in mind that responses are copied verbatim to 10,000+ users - - please refrain from "Me Too"s and clicking on reactions to emails.  That will keep your email environment clean.  Thanks!
NOTICE: This message, including any attachments, may contain confidential and privileged information, including patient information protected by federal and state privacy laws. If you are not the intended recipient, please notify the sender and delete this email and any attachments from your system. Any use, dissemination, distribution, printing, or copying of this email by unauthorized persons is prohibited.